Spots Global Cancer Trial Database for metastatic kidney carcinoma

Every month we try and update this database with for metastatic kidney carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases	NCT04752267	Anatomic Stage ... Clinical Stage ... Glioma Malignant Brain... Metastatic Brea... Metastatic Colo... Metastatic Kidn... Metastatic Lung... Metastatic Mali... Metastatic Mela... Pathologic Stag... Prognostic Stag... Stage IV Colon ... Stage IV Lung C... Stage IV Renal ... Stage IVA Colon... Stage IVA Lung ... Stage IVB Colon... Stage IVB Lung ... Stage IVC Colon...	Computed Tomogr... 18F-FMAU Multiparametric... Positron Emissi...	18 Years -	University of Southern California
Daratumumab in Treating Patients With Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer	NCT03473730	Bladder Urothel... Clear Cell Rena... Malignant Urina... Metastatic Kidn... Stage IV Renal ...	Biopsy Daratumumab Laboratory Biom... Metastasectomy Nephrectomy	18 Years -	M.D. Anderson Cancer Center
Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer	NCT03015740	Clear Cell Rena... Metastatic Kidn... Stage III Renal... Stage IV Renal ...	Laboratory Biom... Nivolumab Quality-of-Life... Questionnaire A... Sitravatinib	18 Years -	M.D. Anderson Cancer Center
Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer	NCT01239342	Metastatic Kidn... Recurrent Renal... Stage III Renal... Stage IV Renal ...	Akt Inhibitor M... Everolimus Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer	NCT01038778	Clear Cell Rena... Metastatic Kidn... Stage III Renal... Stage IV Renal ...	Aldesleukin Computed Tomogr... Entinostat Fludeoxyglucose... Laboratory Biom... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer	NCT01835158	Clear Cell Rena... Metastatic Kidn... Stage III Renal... Stage IV Renal ...	Cabozantinib S-... Laboratory Biom... Sunitinib Malat...	18 Years -	National Cancer Institute (NCI)
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer	NCT03050060	Metastatic Kidn... Recurrent Lung ... Stage IV Cutane... Stage IV Renal ... Stage IV Lung N...	Atezolizumab Hypofractionate... Laboratory Biom... Nelfinavir Mesy... Nivolumab Pembrolizumab	18 Years -	University of Washington
Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer	NCT01239342	Metastatic Kidn... Recurrent Renal... Stage III Renal... Stage IV Renal ...	Akt Inhibitor M... Everolimus Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
CARE1 Pragmatic Clinical Trial	NCT06364631	Metastatic Kidn... Metastatic Kidn...	Nivolumab Ipilimumab Pembrolizumab Cabozantinib Axitinib Lenvatinib	18 Years -	Gustave Roussy, Cancer Campus, Grand Paris
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases	NCT04752267	Anatomic Stage ... Clinical Stage ... Glioma Malignant Brain... Metastatic Brea... Metastatic Colo... Metastatic Kidn... Metastatic Lung... Metastatic Mali... Metastatic Mela... Pathologic Stag... Prognostic Stag... Stage IV Colon ... Stage IV Lung C... Stage IV Renal ... Stage IVA Colon... Stage IVA Lung ... Stage IVB Colon... Stage IVB Lung ... Stage IVC Colon...	Computed Tomogr... 18F-FMAU Multiparametric... Positron Emissi...	18 Years -	University of Southern California
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord	NCT02713269	Malignant Diges... Metastatic Head... Metastatic Kidn... Metastatic Mali... Metastatic Mali... Metastatic Mela... Prostate Carcin... Sarcoma Solid Neoplasm Spinal Cord Com... Stage IV Breast... Stage IV Lung N... Thyroid Gland C...	Computed Tomogr... Quality-of-Life... Questionnaire A... Stereotactic Ra... Thermal Ablatio...	18 Years -	M.D. Anderson Cancer Center
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer	NCT01835158	Clear Cell Rena... Metastatic Kidn... Stage III Renal... Stage IV Renal ...	Cabozantinib S-... Laboratory Biom... Sunitinib Malat...	18 Years -	National Cancer Institute (NCI)
Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer	NCT03015740	Clear Cell Rena... Metastatic Kidn... Stage III Renal... Stage IV Renal ...	Laboratory Biom... Nivolumab Quality-of-Life... Questionnaire A... Sitravatinib	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: